Moreover, antibodies can be potential therapies, too, as it was demonstrated using an adeno-associated virus to deliver antibodies against mutant SOD1 in ALS mouse model, revealing an attenuation of motor loss, a reduction of neural stress and alleviation of gliosis [215]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.